Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Joint pain

Uncertainty on long-term efficacy of osteoarthritis medicines

Out of 31 medicines used to treat knee osteoarthritis, only glucosamine sulphate was associated with significant decreases in pain compared with placebo, research has shown.

Osteoarthritis knee X ray


Medicines for knee osteoarthritis may not be effective in the long term, study shows

There is a lack of evidence that medicines for osteoarthritis are effective in the long term, according to a review in the Journal of the American Medical Association (25 December 2018)[1].

The network meta-analysis used data from 47 randomised controlled trials lasting at least 12 months, including 22,037 people with knee osteoarthritis, which explored the effects of 31 medicines on pain, 13 medicines on physical function and 16 medicines on joint structure.

The team found that only celecoxib and prescription glucosamine sulphate were associated with significant decreases in pain compared with placebo. In subanalyses, including those that excluded studies at high risk of bias, these results only remained significant for prescription glucosamine sulphate.

Glucosamine sulphate was also associated with improvement in physical function and joint structure while celecoxib was not.

While there is good evidence for the efficacy of pharmacological agents in short-term pain relief, much research in osteoarthritis has not considered long-term outcomes, the researchers explained.

“Larger randomised clinical trials are needed to resolve the uncertainty around the long-term efficacy of medications for knee osteoarthritis,” they concluded.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2019.20206100

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.